What was once an emergent market trend is now an established market need: decentralized clinical trial technology. Decentralized clinical trials, also known as virtual or hybrid trials, were already increasingly appealing, but as of late there has been a rapid acceleration in decentralized trial technology adoption.

The need for decentralized trial technology will certainly continue to remain necessary. According to a report from GlobalData published June 2020, approximately 35% of clinical health experts currently use virtual trials and 67% plan to use them in the future.